Dissociation of amyloid biomarkers in PET and CSF in Alzheimer’s disease: a case report

BACKGROUND: Recently, biomarkers have been suggested to be incorporated into diagnostic criteria for Alzheimer’s disease (AD). Regarding disease-specific brain amyloid-beta deposition these comprise low amyloid-beta 1–42 in cerebrospinal fluid (CSF) and positive positron emission tomography (PET) am...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroeter, Matthias L., Tiepolt, Solveig, Marschhauser, Anke, Thöne-Otto, Angelika, Hoffmann, Karl-Titus, Barthel, Henryk, Obrig, Hellmuth, Sabri, Osama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548309/
https://www.ncbi.nlm.nih.gov/pubmed/26303364
http://dx.doi.org/10.1186/s12883-015-0410-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548309/
https://www.ncbi.nlm.nih.gov/pubmed/26303364
http://dx.doi.org/10.1186/s12883-015-0410-5

Ejemplares similares